VEDOLIZUMAB, USTEKINUMAB AND TOFACITINIB AS TRIPLE THERAPY FOR ULCERATIVE COLITIS

被引：0
|
作者：
Thurston, Theresa
Moskow, Joshua
Glassner, Kerri
Abraham, Bincy
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [31] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [32] COMBINATION THERAPY DOES NOT IMPROVE CLINICAL AND ENDOSCOPIC REMISSION RATES WITH VEDOLIZUMAB OR USTEKINUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
    Hu, Anne
    Kotze, Paulo G.
    Tan, William
    Jess, Alison T.
    Li, Pei-Shun Mimi
    Kroeker, Karen I.
    Halloran, Brendan P.
    Panaccione, Remo
    Ma, Christopher
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2020, 158 (06) : S53 - S53
  • [33] Vedolizumab for the treatment of ulcerative colitis
    Stallmach, Andreas
    Schmidt, Carsten
    Teich, Niels
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (02) : 165 - 175
  • [34] Vedolizumab for the treatment of ulcerative colitis
    Rietdijk, Svend T.
    D'Haens, Geert R.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (04) : 423 - 430
  • [35] Subcutaneous vedolizumab for ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (11): : 826 - 826
  • [36] Subcutaneous vedolizumab for ulcerative colitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 16 - 16
  • [37] Vedolizumab for the treatment of ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (01) : 129 - 135
  • [38] Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
    Nomura, Kei
    Shibuya, Tomoyoshi
    Odakura, Rina
    Haraikawa, Mayuko
    Ishino, Hirotaka
    Orikasa, Masayuki
    Omori, Masashi
    Koma, Masao
    Ito, Kentaro
    Maruyama, Takafumi
    Nomura, Osamu
    Ishikawa, Dai
    Hojo, Mariko
    Nagahara, Akihito
    BIOMEDICINES, 2024, 12 (09)
  • [39] Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry study
    Straatmijer, T.
    Visschedijk, M.
    de Vries, A.
    Hoentjen, F.
    van Bodegraven, A. A.
    Bodelier, A. G. L.
    de Boer, N. K. H.
    Dijkstra, G.
    Festen, E. A. M.
    Horjus, C.
    Jansen, J. M.
    Jharap, B.
    Mares, W.
    Oldenburg, B.
    Ponsioen, C. Y.
    Romkens, T. E. H.
    Srivastava, N.
    van der Voorn, M. M.
    West, R. L.
    van der Woude, J. C.
    Wolvers, M. D. J.
    Pierik, M.
    van der Meulen, A. E.
    Duijvestein, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I119 - I120
  • [40] The Comparison of Short-Term Efficacy of Treatments Between Tofacitinib and Vedolizumab in Patients With Ulcerative Colitis
    Takada, Yoshiaki
    Naganuma, Makoto
    Mutaguchi, Makoto
    Fukuda, Tomohiro
    Mikami, Yohei
    Hagihara, Yuya
    Tanemoto, Shun
    Umeda, Satoko
    Nomura, Ena
    Yoshida, Kosuke
    Yoshimatsu, Yusuke
    Ono, Keiko
    Sugimoto, Shinya
    Nanki, Kosaku
    Fukuhara, Kayoko
    Sujino, Tomohisa
    Takabayashi, Kaoru
    Ogata, Haruhiko
    Iwao, Yasushi
    Kanai, Takanori
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S24 - S25
12345